As the science of Pharmaceutics has made concrete findings
on carbohydrates, it has been deduced that a large number of carbohydrates and
carbohydrate derivatives can be used as therapeutics or diagnostic drugs.
Tuesday, December 22, 2015
Friday, December 18, 2015
Role of Carbohydrates in Development of Biopharmaceuticals
Despite their large scale accessibility, the medicinal
aspect of carbohydrates remained an allusive mystery until last century when
scientists first discovered the diagnostic properties of complex sugars.
Carbohydrates were not extensively researched up till now as their complex
structure and strong intermolecular bonds made it difficult to study them via
conventional methods.
With the advent of higher technological inventions and
methods in pharmaceutics, it was found out that carbohydrates play an important
role in diagnostic and therapeutic aspects of various diseases such as
tuberculosis, cancer, and diabetes. In this article, we talk about how glycans,
an active class of carbohydrates, are significant in the manufacturing of
various biopharmaceutical drugs.
Evolution of Glycan Structure in Drug Development
Functional Glycomics
Biological structures based on the configuration of a glycan
molecule reflect their evolutionary history and functional aspects when it
comes to differentiation, cell to cell recognition, inflammation,
fertilization, development, and cell adhesion. The field of studying these
evolutionary functions of glycans is known as Functional Glycomics.
Disease Fighting Capabilities of Glycans
Changes in the glycan component of glycoproteins lead to
various medical conditions including congenital disorders of glycosylation
(CDGs), rheumatoid arthritis, atherosclerosis, diabetes, Alzheimer’s disease, and
muscle dystrophy. Reports also indicate that some mutations in the glycan
component may also lead to different types of cancer. As a result of
heterogeneity of glycans, rooting in their complex, non-template structures
which drive biosynthesis, glycans are isolated from other cells and tissues.
However, they form strong bonds with molecules they have high chemical affinity
with.
Screening of Glycans
It is vital to mention here that glycans can be controlled
by the levels of glycosidases present, nucleotide transporters, degree of gene
expression of the glycosyltransferases and glycosidases, substrate availability,
and nucleotide donors. Thus, in order to know the degree of control glycans
required in a chemical reaction, it is vital to have a thorough knowledge of
Functioal Glycomics.
During screening the glycans for their functionality, high
resolution, and highly sensitive analytical techniques are required for a
high-throughput results. After screening and categorization, these glycans can
be then studied to identify the trigger points which lead to afore mentioned
medical conditions and how to avoid them.
Watson
International is a chemical trading company which has developed an entire product line based on
drugs derived from carbohydrates. To view the products, please click
here.
Thursday, November 26, 2015
Wednesday, November 25, 2015
Carbohydrate Polymers: Properties and Applications
Carbohydrates play a key role in numerous biochemical and
biological processes, which include cell differentiation and maturation,
fertilization, and protein folding and degradation. The carbohydrate polymer
branch of study encompasses the potential uses in industrial applications of
carbohydrates, such as in food, paper, adhesives, textiles, biorefining, and
pharmaceuticals.
This article will focus on the development in the field of
carbohydrate binding modular applications in the biotechnological and
pharmaceutical fields.
Introduction
Polysaccharide Polymers
Polysaccharides belong to the class of complex carbohydrates
which is made up of numerous monosaccharide units held together by glycosidic
bonds. Polysaccharide film formation and its mechanical and chemical properties
help find new horizons in pharmaceutical production.
Oligosaccharide Polymers
Furthermore, another class of carbohydrates,
oligosaccharides, is making waves in the field of research and development in
order to manufacture drugs with nutra-ceutical applications.
Carbohydrate-active enzymes (CAZymes) in Polymer Formation
These enzymes are essential in the manufacturing and
breakdown of complex carbohydrates and glyco conjugates. Apart from belonging
in the catalytic domain of enzymes, CAZymes also represent a substrate binding
module, which is collectively known as carbohydrate binding catalytic domain.
Carbohydrate binding Catalytic Domain
This new domain has its own independent functions and folds
in a chemical reaction. Almost 7% of the CAZymes exhibit nearly one
carbohydrate binding module. Currently, fifty eight carbohydrate binding
modules are extensively being studied. They present a considerable amount of
heterogeneity and binding particulars towards crystalline and amorphous
polysaccharides.
Carbohydrate binding Modules and Proteins
These carbohydrate binding modules are famous for initiating
the activity of enzymes by targeting a prolonged interaction with the
substrate. Carbohydrate binding modules are independent of other protein
molecules, thus they make for an excellent option for several applications
which involve enzyme proteolysis and DNA recombinant technology.
Carbohydrates are relatively an untapped resource in the
field of pharmaceutics and drug development due to the extensive technological
expertise required for their analysis, complex bond linkages, and intricate
chemistries between the molecules.
This is why Watson International, an eminent chemical trading company,
has invested time and energy in the research and development of carbohydrate
based pharmaceutical drugs to offer an easier diagnostic and therapeutic option
for the people. Ailments like tuberculosis and diabetes have shown positive
results when treated with carbohydrate based drugs. The company also offers an
array of chemical compounds from precious metal catalysts to cosmetics. For further information,
please click here
to view their products.
Subscribe to:
Comments (Atom)


